Page 804 - Coronavirus Vaccine

Pfizer confirms possible November coronavirus vaccine application

Safety review dictates the timeline, with the Food and Drug Administration requiring that at least half the people in the study be watched for side effects for two months

Britain moves closer to Covid-19 vaccine trials that infect volunteers

If agreed, this would involve creating a human challenge study model that could be used should such trials gain ethical and safety approval from regulators

Remdesivir, HCQ don't aid much in recovery of Covid-19 patients: WHO trials

While Gilead calls for review, the findings can have significant impact on the growing demand of remdesivir

Panel urges granting Dr Reddy's permission for Russia vaccine phase 2 trial

The SEC had on October 5 asked the firm to re-apply stating it will have to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India

WHO in dialogue with Russia on its second Covid-19 vaccine candidate

"We will only be able to have a position on a vaccine when we see results of the phase 3 clinical trials," WHO Chief Scientist Soumya Swaminathan told a news conference in Geneva

Lockdown impact : L&T Hyderabad Metro Rail suffers Rs 916 cr loss during H1

: L&T Metro Rail (Hyderabad) suffered Rs 916 crore loss during the first six months of the current fiscal following a prolonged lockdown to contain coronavirus, the company that operates the elevated rail corridor here, has said in a disclosure. The total income from operations plunged to just Rs 60 crore during the period under discussion. "The operations of the company were suspended for significant part of the period in the current financial year due to lockdown imposed by Government on account of COVID 19. Hence the disclosure of the ratios is not applicable,"it said. Metrorailservices in the city were suspended in March last week as part of lockdown to contain the spread of coronavirus. The Centre as part of Unlock-4 allowed the services from September 7. It incurred Rs 383 crore loss during the last financial year. L&T in its latest annual report said it may invoke force majeure clause with Telangana Government seeking extension of the concession period ...

Pfizer could apply for emergency use of Covid-19 vaccine by late Nov

It would be the first time that Pfizer or any other leading Western vaccine developer provided such a specific timeline.

World Coronavirus Dispatch: Remdesivir not an effective cure, say WHO study

New US jobless claims rise to 900,000, stricter lockdown in London, Japanese theme park morphs into office, and other pandemic-related news across the globe

India Coronavirus Dispatch: How cinema halls are coping with the new normal

Haryana's recovery rate crosses 91%, Delhi back as No.1 infected city, new study focusses on 'Long Covid'--news on how the country is dealing with the pandemic

Covid-19 stories in pics: 7 key updates that you may have missed this week

Here's a weekly round up of stories and updates related to coronavirus pandemic in brief

Chinese Covid-19 vaccine candidate shows promise in human trial: Study

One of China's leading Covid-19 vaccine candidates, called BBIBP-CorV, was shown to be safe and elicited immune response in a small early-phase human trial, researchers said on Friday

India has potential to increase Covid testing 10-fold: Kiran Mazumdar-Shaw

India, which in March imposed the largest nationwide lockdown globally in response to the pandemic, was taken by surprise by the surging number of infections when it started removing the restrictions

India coronavirus update: Covid-19 caseload rises to 7,370,468

India's Covid-19 caseload rose to 7,370,468 with 63,371 new infections being reported in a day, while the number of people who have recuperated from the disease crossed 6.4 million

Coronavirus LIVE: PM calls for scaling up of Covid-19 testing, sero surveys

Coronavirus update: Maharashtra has 1,554,389 coronavirus cases, Andhra Pradesh 767,465, Karnataka 735,371, Tamil Nadu 670,392 and UP 444,711. Stay tuned for coronavirus India LIVE update

Oxford scientists develop five-minute rapid coronavirus antigen test

The university said it hoped to start product development of the testing device in early 2021 and have an approved device available six months afterwards

Dr Reddy's: Progress in Covid vaccine trials to boost firm's growth outlook

Good momentum in US and domestic sales, along with Covid-19 treatment portfolio is already driving analysts to upgrade earnings estimates

Apollo Hospitals gears up to administer 1 million Covid-19 vaccines daily

According to the hospital chain, its cold chain network can deliver the vaccine in less than 30 mins and in maximum 48 hours across the country

3 firms get clinical trial approval for alternative Covid-19 drugs

The drug 2-DG is not yet an approved drug, but there have been multiple studies across the globe for treatment of cancers

How to ensure quick Covid vaccination of billions? Online gamers may help

Problem of building an mRNA which can stay effective for a long time in a regular refrigerator is currently being worked on by thousands of people around the world - by playing a game called Eterna

India expected to have Covid-19 vaccine in next few months: Harsh Vardhan

He made the comments at the Annual General Meeting of Indian Red Cross Society (IRCS) and St. John's Ambulance